Published by Chapman and Hall/CRC, 2019
ISBN 10: 1498761305 ISBN 13: 9781498761307
Language: English
Seller: HPB-Red, Dallas, TX, U.S.A.
Hardcover. Condition: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority!
Seller: ThriftBooks-Dallas, Dallas, TX, U.S.A.
Paperback. Condition: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less 1.35.
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New.
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Condition: New.
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New. 1 edition NO-PA16APR2015-KAP.
Seller: California Books, Miami, FL, U.S.A.
Condition: New.
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: As New. Unread book in perfect condition.
Seller: Majestic Books, Hounslow, United Kingdom
Condition: New.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
US$ 76.17
Quantity: Over 20 available
Add to basketCondition: New.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
US$ 81.03
Quantity: Over 20 available
Add to basketCondition: New. In.
Published by Chapman and Hall/CRC, 2019
ISBN 10: 1498761305 ISBN 13: 9781498761307
Language: English
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New.
Published by Chapman and Hall/CRC 2021-03-31, 2021
ISBN 10: 0367727072 ISBN 13: 9780367727079
Language: English
Seller: Chiron Media, Wallingford, United Kingdom
Paperback. Condition: New.
Published by Chapman and Hall/CRC, 2019
ISBN 10: 1498761305 ISBN 13: 9781498761307
Language: English
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: As New. Unread book in perfect condition.
Published by Chapman and Hall/CRC, 2019
ISBN 10: 1498761305 ISBN 13: 9781498761307
Language: English
Seller: Ria Christie Collections, Uxbridge, United Kingdom
US$ 90.28
Quantity: Over 20 available
Add to basketCondition: New. In.
Published by Chapman and Hall/CRC, 2019
ISBN 10: 1498761305 ISBN 13: 9781498761307
Language: English
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: New.
Published by Chapman and Hall/CRC 2019-06-28, 2019
ISBN 10: 1498761305 ISBN 13: 9781498761307
Language: English
Seller: Chiron Media, Wallingford, United Kingdom
Hardcover. Condition: New.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
US$ 90.72
Quantity: Over 20 available
Add to basketCondition: As New. Unread book in perfect condition.
Published by Chapman and Hall/CRC, 2019
ISBN 10: 1498761305 ISBN 13: 9781498761307
Language: English
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: As New. Unread book in perfect condition.
Seller: Revaluation Books, Exeter, United Kingdom
Paperback. Condition: Brand New. 442 pages. 9.21x6.14x1.10 inches. In Stock.
Published by Taylor and Francis Inc, US, 2019
ISBN 10: 1498761305 ISBN 13: 9781498761307
Language: English
Seller: Rarewaves.com USA, London, LONDO, United Kingdom
Hardback. Condition: New. Cancer is a major healthcare burden across the world and impacts not only the people diagnosed with various cancers but also their families, carers, and healthcare systems. With advances in the diagnosis and treatment, more people are diagnosed early and receive treatments for a disease where few treatments options were previously available. As a result, the survival of patients with cancer has steadily improved and, in most cases, patients who are not cured may receive multiple lines of treatment, often with financial consequences for the patients, insurers and healthcare systems. Although many books exist that address economic evaluation, Economic Evaluation of Cancer Drugs using Clinical Trial and Real World Data is the first unified text that specifically addresses the economic evaluation of cancer drugs. The authors discuss how to perform cost-effectiveness analyses while emphasising the strategic importance of designing cost-effectiveness into cancer trials and building robust economic evaluation models that have a higher chance of reimbursement if truly cost-effective. They cover the use of real-world data using cancer registries and discuss how such data can support or complement clinical trials with limited follow up. Lessons learned from failed reimbursement attempts, factors predictive of successful reimbursement and the different payer requirements across major countries including US, Australia, Canada, UK, Germany, France and Italy are also discussed. The book includes many detailed practical examples, case studies and thought-provoking exercises for use in classroom and seminar discussions. Iftekhar Khan is a medical statistician and health economist and a lead statistician at Oxford Unviersity's Center for Statistics in Medicine. Professor Khan is also a Senior Research Fellow in Health Economics at University of Warwick and is a Senior Statistical Assessor within the Licensing Division of the UK Medicine and Health Regulation Agency. Ralph Crott is a former professor in Pharmacoeconomics at the University of Montreal in Quebec, Canada and former head of the EORTC Health Economics Unit and former senior health economist at the Belgian HTA organization.Zahid Bashir has over twelve years experience working in the pharmaceutical industry in medical affairs and oncology drug development where he is involved in the design and execution of oncology clinical trials and development of reimbursement dossiers for HTA submission.
Condition: New.
Published by Chapman and Hall/CRC, 2019
ISBN 10: 1498761305 ISBN 13: 9781498761307
Language: English
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Condition: New.
Published by Chapman and Hall/CRC, 2019
ISBN 10: 1498761305 ISBN 13: 9781498761307
Language: English
Seller: California Books, Miami, FL, U.S.A.
Condition: New.
Published by Chapman and Hall/CRC, 2019
ISBN 10: 1498761305 ISBN 13: 9781498761307
Language: English
Seller: Majestic Books, Hounslow, United Kingdom
Condition: New.
Published by Chapman and Hall/CRC, 2019
ISBN 10: 1498761305 ISBN 13: 9781498761307
Language: English
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New.
Published by Chapman and Hall/CRC, 2019
ISBN 10: 1498761305 ISBN 13: 9781498761307
Language: English
Seller: Biblios, Frankfurt am main, HESSE, Germany
Condition: New.
Published by Taylor and Francis Inc, US, 2019
ISBN 10: 1498761305 ISBN 13: 9781498761307
Language: English
Seller: Rarewaves.com UK, London, United Kingdom
Hardback. Condition: New. Cancer is a major healthcare burden across the world and impacts not only the people diagnosed with various cancers but also their families, carers, and healthcare systems. With advances in the diagnosis and treatment, more people are diagnosed early and receive treatments for a disease where few treatments options were previously available. As a result, the survival of patients with cancer has steadily improved and, in most cases, patients who are not cured may receive multiple lines of treatment, often with financial consequences for the patients, insurers and healthcare systems. Although many books exist that address economic evaluation, Economic Evaluation of Cancer Drugs using Clinical Trial and Real World Data is the first unified text that specifically addresses the economic evaluation of cancer drugs. The authors discuss how to perform cost-effectiveness analyses while emphasising the strategic importance of designing cost-effectiveness into cancer trials and building robust economic evaluation models that have a higher chance of reimbursement if truly cost-effective. They cover the use of real-world data using cancer registries and discuss how such data can support or complement clinical trials with limited follow up. Lessons learned from failed reimbursement attempts, factors predictive of successful reimbursement and the different payer requirements across major countries including US, Australia, Canada, UK, Germany, France and Italy are also discussed. The book includes many detailed practical examples, case studies and thought-provoking exercises for use in classroom and seminar discussions. Iftekhar Khan is a medical statistician and health economist and a lead statistician at Oxford Unviersity's Center for Statistics in Medicine. Professor Khan is also a Senior Research Fellow in Health Economics at University of Warwick and is a Senior Statistical Assessor within the Licensing Division of the UK Medicine and Health Regulation Agency. Ralph Crott is a former professor in Pharmacoeconomics at the University of Montreal in Quebec, Canada and former head of the EORTC Health Economics Unit and former senior health economist at the Belgian HTA organization.Zahid Bashir has over twelve years experience working in the pharmaceutical industry in medical affairs and oncology drug development where he is involved in the design and execution of oncology clinical trials and development of reimbursement dossiers for HTA submission.
Published by Chapman and Hall/CRC, 2019
ISBN 10: 1498761305 ISBN 13: 9781498761307
Language: English
Seller: Mispah books, Redhill, SURRE, United Kingdom
Hardcover. Condition: New. New. Ships from Multiple Locations. book.
Seller: Revaluation Books, Exeter, United Kingdom
Hardcover. Condition: Brand New. 1st edition. 415 pages. 9.50x6.50x1.25 inches. In Stock.
Seller: Biblios, Frankfurt am main, HESSE, Germany
Condition: New. PRINT ON DEMAND.